Insider Trading & Ownership - REICIN ALISE

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for REICIN ALISE

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-14
Option Award
2023-06-15
6:04 pm
N/A
2033-06-14
Homology Medicines Inc.FIXXREICIN ALISE
Director
23,000$023,000
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:34 pm
N/A
2033-06-07
Sana Biotechnology Inc.SANAREICIN ALISE
Director
65,000$065,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:05 pm
N/A
2032-06-15
Homology Medicines Inc.FIXXREICIN ALISE
Director
18,000$018,000
(Direct)
View
2022-06-06
Option Award
2022-06-08
6:39 pm
N/A
2032-06-05
Sana Biotechnology Inc.SANAREICIN ALISE
Director
65,000$065,000
(Direct)
View
2021-06-17
Option Award
2021-06-22
5:40 pm
N/A
2031-06-17
Homology Medicines Inc.FIXXREICIN ALISE
Director
18,000$018,000
(Direct)
View
2021-02-03
Option Award(A)
2021-02-18
6:59 pm
N/A
2031-02-02
Sana Biotechnology Inc.SANAREICIN ALISE
Director
11,795$011,795
(Direct)
View
2021-02-03
Option Award
2021-02-05
5:15 pm
N/A
2031-02-02
Sana Biotechnology Inc.SANAREICIN ALISE
Director
7,000$07,000
(Direct)
View

Ownership
2021-02-03
9:09 pm
N/A
2030-12-07
Sana Biotechnology Inc.SANAREICIN ALISE
Director
0$093,750
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:33 pm
N/A
2030-06-10
Homology Medicines Inc.FIXXREICIN ALISE
Director
18,000$018,000
(Direct)
View
2019-11-20
Disposition
2019-11-22
07:31 am
N/A
2028-11-01
CELGENE CORPCELGREICIN ALISE
PRES., GLOBAL CLINICAL DEV.
148,582$00
(Direct)
View
2019-11-20
Option Award
2019-11-22
07:31 am
N/A
N/A
CELGENE CORPCELGREICIN ALISE
PRES., GLOBAL CLINICAL DEV.
37,434$00
(Direct)
View
2019-11-01
Tax Withholding
2019-11-04
4:05 pm
N/A
N/A
CELGENE CORPCELGREICIN ALISE
PRES., GLOBAL CLINICAL DEV.
4,722$108.5330,988
(Direct)
View
2019-11-01
Exercise
2019-11-04
4:05 pm
N/A
N/A
CELGENE CORPCELGREICIN ALISE
PRES., GLOBAL CLINICAL DEV.
11,903$030,988
(Direct)
View
2019-07-11
Option Award
2019-07-15
5:36 pm
N/A
2029-07-11
Homology Medicines Inc.FIXXREICIN ALISE
Director
31,160$031,160
(Direct)
View
(A) Indicate amendment filing.